晚期上颌牙龈鳞状细胞癌经动脉灌注化疗同步放疗的预后因素与治疗结局
本研究回顾性分析46例晚期上颌牙龈鳞状细胞癌患者,采用动脉灌注多西他赛60 mg/m2联合顺铂150 mg/m2及三维适形放疗60 Gy/30次同步治疗6周。中位随访40个月,3年总生存率64.3%,局部区域控制率84.3%;N0-1患者总生存率显著高于N≥2患者(P<.05)。未观察到5级毒性。
要点
- 动脉灌注化疗同步放疗治疗晚期上颌牙龈鳞癌,3年总生存率64.3%,局部区域控制率84.3%。
- N0-1患者总生存率显著高于N≥2患者(P<.05)。
- 未观察到5级毒性。
核心结论
- 动脉灌注化疗同步放疗对晚期上颌牙龈鳞状细胞癌有效。
研究设计与样本
- 回顾性分析46例晚期上颌牙龈鳞状细胞癌患者。
- 治疗方案为动脉灌注化疗(多西他赛总剂量60 mg/m2联合顺铂总剂量150 mg/m2)及基于三维计算机断层扫描的每日常规放疗(总剂量60 Gy/30次),共6周。
主要发现
- 中位随访期40个月(范围3-110个月)。
- 全部患者3年总生存率为64.3%,局部区域控制率为84.3%。
- N0-1患者的总生存率显著高于N≥2患者(P<.05)。
- 未观察到5级毒性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to evaluate the prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma (SCC) treated with intra-arterial infusion chemotherapy concurrent with radiotherapy. METHODS: A total of 46 patients were reviewed retrospectively in this study. The treatment schedule comprised intra-arterial chemotherapy (total, 60 mg/m2 docetaxel and 150 mg/m2 cisplatin) and three-dimensional computed tomography based, daily conventional radiotherapy (total, 60 Gy/30 fr) for 6 weeks. RESULTS: The median follow-up period was 40 months (range, 3-110 months). The 3-year overall survival and locoregional control rates for all patients were 64.3% and 84.3%, respectively. The OS rate of the patients with N0-1 was significantly higher than that of the patients with N ≥ 2 (P < .05). No grade 5 toxicities were observed. CONCLUSIONS: Intra-arterial infusion chemotherapy concurrent with radiotherapy was effective for advanced maxillary gingival SCC.
引用
- Hayashi Y, Osawa K, Nakakaji R, et al. Prognostic factors and treatment outcomes of advanced maxillary gingival squamous cell carcinoma treated by intra-arterial infusion chemotherapy concurrent with radiotherapy. Head Neck. 2019. PMID: 30694002. doi:10.1002/hed.25607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。